Lori Clapper

Hikma Pharmaceuticals announced last week that it will acquire assets of Bedford Laboratories, Ben Venue's U.S. generic injectables business. Details of the agreement include a total consideration of up to $300 million, including a $225 million upfront payment and a further $75 million in contingent cash payments dependent on achievement of performance-related milestones, over a period of five years.  Continue Reading..

CPhI Worldwide, part of UBM Live's Pharmaceutical Portfolio, has released initial insights from its comprehensive analysis on Turkey's pharmaceutical manufacturing industry. The full report will be made available at CPhI Istanbul, taking place June 4th to 6th. As part of the research, analysts surveyed Turkish manufacturers concerning the conditions for both foreign and domestic companies. The results were compiled in conjunction with Global...  Continue Reading..

The GAVI global vaccines alliance, which funds immunization roll-out programs in poor nations across the globe, is on a critical mission to immunize 300 million more children against life-threatening diseases through 2020, saving up to 6 million lives worldwide, Reuters reported. The price tag: $7.5 billion.  Continue Reading..

GlaxoSmithKline (GSK) unveiled plans to build a £25-28 million manufacturing facility for active pharmaceutical ingredients (APIs), expanding the role of its current Montrose plant in the UK.  Continue Reading..

After two unsuccessful attempts to take over India’s Cipla Ltd. since 2012, Teva Pharmaceuticals is upping the ante with a $6 billion offer, LiveMint reported last week.  Continue Reading..

Last week, the FDA launched its Drug Controller General of India workshops, during which a senior official argued that quality must be the top priority for Indian pharma companies—and indeed, for all international drug companies.  Continue Reading..

Sun Pharma plans to close its Detroit manufacturing plant Caraco Pharmaceuticals this summer, putting 178 jobs on the chopping block. The closure is part of U.S. manufacturing consolidation efforts, the India-based company announced Friday.  Continue Reading..

More than 22 million children around the world do not get vaccinated. Vaccines are some of the most important life-saving medical tools in the world, and each year, organizations such as Doctors without Borders/Médecins Sans Frontières (MSF) facilitate the delivery of measles, yellow fever, meningitis, and other vaccines to children in developing countries.  Continue Reading..

In an effort to streamline business, Merck announced it may sell off a number of its off-patent drugs, called “diversified brands” — a move which could bring in more than $15 billion, according to Reuters.  Continue Reading..

CPhI, a provider of innovative, interactive, and educational programs to network, learn, and gain new insights into the world of pharma, released new insights last week into current pharmaceutical manufacturing practices and processes.  Continue Reading..